bioactivity | FT011 is an anti-fibrotic agent that reduces mRNA expression of collagen I and III and inhibits collagen synthesis. |
in vivo study | FT011 (100 mg/kg B.I. d., p.o., for 4 weeks) improvements the cardiac function and and myocardial reconstruction in myocardial infection rats. Animal Model: Seventy male Sprague Dawley (SD) rats (weighting 200-250g) Dosage: 100 mg/kg Administration: B.I.D., p.o. on day 7 after surgery, for 4 weeks Result: Increased ejection fraction, fraction shortening and preload recruitable stroke work. |
Animal Model:
| Seventy male Sprague Dawley (SD) rats (weighing 200-250 g) |
Dosage:
| 100 mg/kg |
Administration:
| B.I.D., p.o. on day 7 after surgery, for 4 weeks |
Result:
| Increased ejection fraction, fraction shortening and preload recruitable stroke work. |